Impact of Covıd-19 Pandemıc on Severe Ventrıcular Arrhythmıa and Icd Therapy

BACKGROUND AND OBJECTIVES: The regular clinical follow-up of the patient with implantable cardioverter-defibrillator (ICD) device was seriously affected by COVID-19 outbreak. Due to high risk contamination, patients didn’t admit clinics for ICD control. It has been observed that arrhythmic events increased during In this study, we aimed investigate frequency severe ventricular arrhythmias and therapy in ICD. METHODS: single center-observational assessed therapies analyzing recorded data 33 (24 males, 72.7%) 3 months before after getting pandemic Van, Turkey, between 15 August 2020 January 2021. RESULTS: Before diagnosis COVID-19, 6 tachycardias 1 fibrillation episode were observed. When analyzed records 17 tachycardia, episodes Considering therapies, 5 these tachyarrhythmias terminated anti-tachycardia pacing (ATP) 2 shock COVID-19. After 14 them ATP, therapy. CONCLUSION: effects pandemic, especially on arrhythmia, have not reported sufficiently. our it life-threatening first month